Home › Compare › CEOS vs BTI

CEOS vs BTI: Dividend Comparison 2026

CEOS yields 76923.08% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CEOS wins by $3.5207463509675137e+25M in total portfolio value
10 years
CEOS
CEOS
● Live price
76923.08%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.5207463509675137e+25M
Annual income
$35,117,657,238,443,270,000,000,000,000,000.00
Full CEOS calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — CEOS vs BTI

📍 CEOS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCEOSBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CEOS + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CEOS pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CEOS
Annual income on $10K today (after 15% tax)
$6,538,461.54/yr
After 10yr DRIP, annual income (after tax)
$29,850,008,652,676,780,000,000,000,000,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, CEOS beats the other by $29,850,008,652,676,780,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CEOS + BTI for your $10,000?

CEOS: 50%BTI: 50%
100% BTI50/50100% CEOS
Portfolio after 10yr
$1.7603731754837569e+25M
Annual income
$17,558,828,619,221,635,000,000,000,000,000.00/yr
Blended yield
99.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

CEOS
No analyst data
Altman Z
-2.9
Piotroski
4/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CEOS buys
0
BTI buys
0
No recent congressional trades found for CEOS or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCEOSBTI
Forward yield76923.08% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$3.5207463509675137e+25M$37.7K ✓
Annual income after 10y$35,117,657,238,443,270,000,000,000,000,000.00 ✓$2,786.64
Total dividends collected$3.520157521397876e+25M$14.3K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CEOS vs BTI ($10,000, DRIP)

YearCEOS PortfolioCEOS Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$7,703,008$7,692,307.69$11,299$598.92+$7.69M → CEOS
2$5,545,990,379$5,537,748,161.26$12,794$703.91+$5545.98M → CEOS
3$3,732,151,735,917$3,726,217,526,211.36$14,518$829.07+$3732151.72M → CEOS
4$2,347,491,508,714,269$2,343,498,106,356,837.00$16,513$978.64+$2347491508.70M → CEOS
5$1,380,119,533,083,814,100$1,377,607,717,169,489,700.00$18,827$1,157.84+$1380119533083.80M → CEOS
6$758,404,537,995,947,800,000$756,927,810,095,548,100,000.00$21,518$1,373.12+$758404537995947.75M → CEOS
7$389,547,620,856,236,000,000,000$388,736,128,000,580,400,000,000.00$24,657$1,632.46+$389547620856236032.00M → CEOS
8$187,025,031,600,452,680,000,000,000$186,608,215,646,136,520,000,000,000.00$28,329$1,945.74+$187025031600452665344.00M → CEOS
9$83,931,094,609,218,200,000,000,000,000$83,730,977,825,405,720,000,000,000,000.00$32,637$2,325.33+$8.39310946092182e+22M → CEOS
10$35,207,463,509,675,137,000,000,000,000,000$35,117,657,238,443,270,000,000,000,000,000.00$37,708$2,786.64+$3.5207463509675137e+25M → CEOS

CEOS vs BTI: Complete Analysis 2026

CEOS — Stock

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Full CEOS Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this CEOS vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CEOS vs SCHDCEOS vs JEPICEOS vs OCEOS vs KOCEOS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.